Current treatment options for HNSCC include surgery, radiation therapy, chemotherapy, and more recently, treatment with anti-EGFR antibodies and checkpoint inhibitors for recurrent/metastasising HNSCC. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.